Multiple Manufacturers

LINCOCIN

Manufacturer:

Multiple Manufacturers

Lincocin HCPCS:

J2010

HCPCS Code Descriptor:

Injection, lincomycin hcl, up to 300 mg

Category:

J Code

Lincocin NDCs:

25021-0193-10, 39822-0353-06, 72485-0114-01, 00009-0104-04, 00009-0107-04, 00009-0555-02, 00009-0555-01, 39822-0350-02, 72485-0115-10, 25021-0193-02

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

25021-0193-10, 39822-0353-06, 72485-0114-01, 00009-0104-04, 00009-0107-04, 00009-0555-02, 00009-0555-01, 39822-0350-02, 72485-0115-10, 25021-0193-02

About Lincocin:

LINCOCIN is a medication manufactured by multiple manufacturers and aligned to the J Code: J2010. LINCOCIN is administered via the injection route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J2010 Added Date:

January 1, 1982

J2010 Effective Date:

January 1, 1997

J2010 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lincocin billing and coding information.
Lincocin patient assistance information can be found through Pfizer Rx Pathways at the URL: http://www.pfizerrxpathways.com/
Our team is still working to identify a prescribing information source for LINCOCIN
Our team has not yet identified a source of side effects information for LINCOCIN. Please check back in a few weeks.